BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 27210295)

  • 41. Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes.
    Sahoo SS; Kozyra EJ; Wlodarski MW
    Best Pract Res Clin Haematol; 2020 Sep; 33(3):101197. PubMed ID: 33038986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Germline Genetic Predisposition to Hematologic Malignancy.
    Furutani E; Shimamura A
    J Clin Oncol; 2017 Mar; 35(9):1018-1028. PubMed ID: 28297620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidental detection of germline variants of potential clinical significance by massively parallel sequencing in haematological malignancies.
    Yannakou CK; Jones K; Ryland GL; Thompson ER; Reid G; McBean M; Trainer A; Westerman D; Blombery P
    J Clin Pathol; 2018 Jan; 71(1):84-87. PubMed ID: 28801348
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Predisposition to pediatric and hematologic cancers: a moving target.
    Malkin D; Nichols KE; Zelley K; Schiffman JD
    Am Soc Clin Oncol Educ Book; 2014; ():e44-55. PubMed ID: 24857136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How I diagnose myeloid neoplasms with germline predisposition.
    Patel N; Calvo KR
    Am J Clin Pathol; 2023 Oct; 160(4):352-364. PubMed ID: 37458302
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Germline Variants and Characteristic Features of Hereditary Hematological Malignancy Syndrome.
    Arai H; Matsui H; Chi S; Utsu Y; Masuda S; Aotsuka N; Minami Y
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Discussing and managing hematologic germ line variants.
    Kohlmann W; Schiffman JD
    Blood; 2016 Nov; 128(21):2497-2503. PubMed ID: 27881370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41.
    Homan CC; Drazer MW; Yu K; Lawrence DM; Feng J; Arriola-Martinez L; Pozsgai MJ; McNeely KE; Ha T; Venugopal P; Arts P; King-Smith SL; Cheah J; Armstrong M; Wang P; Bödör C; Cantor AB; Cazzola M; Degelman E; DiNardo CD; Duployez N; Favier R; Fröhling S; Rio-Machin A; Klco JM; Krämer A; Kurokawa M; Lee J; Malcovati L; Morgan NV; Natsoulis G; Owen C; Patel KP; Preudhomme C; Raslova H; Rienhoff H; Ripperger T; Schulte R; Tawana K; Velloso E; Yan B; Kim E; Sood R; Hsu AP; Holland SM; Phillips K; Poplawski NK; Babic M; Wei AH; Forsyth C; Mar Fan H; Lewis ID; Cooney J; Susman R; Fox LC; Blombery P; Singhal D; Hiwase D; Phipson B; Schreiber AW; Hahn CN; Scott HS; Liu P; Godley LA; Brown AL;
    Blood Adv; 2023 Oct; 7(20):6092-6107. PubMed ID: 37406166
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Familial platelet disorder with predisposition to myeloid leukemia (FPD/AML): a case report and literature review].
    Zhang RR; Chen XJ; Ren YY; Yang WY; Zhu XF
    Zhonghua Xue Ye Xue Za Zhi; 2021 Apr; 42(4):308-312. PubMed ID: 33979975
    [No Abstract]   [Full Text] [Related]  

  • 51. Recognizing familial myeloid leukemia in adults.
    Nickels EM; Soodalter J; Churpek JE; Godley LA
    Ther Adv Hematol; 2013 Aug; 4(4):254-69. PubMed ID: 23926458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia.
    Banaszak LG; Cabral PL; Smith-Simmer K; Hassan A; Brunner M; Fallon M; Shoger K; Lovrien L; Golner D; Zurbriggen L; Mattison R; Gahvari Z; Hall A; Nadiminti K; Reinig E; Churpek JE
    JCO Precis Oncol; 2024 Jun; 8():e2300518. PubMed ID: 38848520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recognition of familial myeloid neoplasia in adults.
    Brown AL; Churpek JE; Malcovati L; Döhner H; Godley LA
    Semin Hematol; 2017 Apr; 54(2):60-68. PubMed ID: 28637618
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Myeloid malignancies with somatic
    Alfayez M; Wang SA; Bannon SA; Kontoyiannis DP; Kornblau SM; Orange JS; Mace EM; DiNardo CD
    Leuk Lymphoma; 2019 Aug; 60(8):2025-2033. PubMed ID: 30648453
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A new form of familial platelet disorder caused by germline mutations in RUNX1 in a pedigree].
    Guan J; Wang LL; Wang CY; Zhu XM; Shuai HZ; Yi X; Zou L; Yu D; Cheng H
    Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):393-400. PubMed ID: 37032134
    [No Abstract]   [Full Text] [Related]  

  • 56. [Management of genetic predisposition to hematologic malignancies in patients undergoing allogeneic hematopoietic cell transplantation (HCT): Guidelines from the SFGM-TC].
    Coiteux V; Fenwarth L; Duployez N; Ainaoui M; Borel C; Polomeni A; Yakoub-Agha I; Chalandon Y
    Bull Cancer; 2023 Feb; 110(2S):S13-S29. PubMed ID: 36307324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inherited DNA repair gene mutations detected by tumor next generation sequencing in urinary tract cancers.
    Gupta S; Greenberg S; Grimmett J; Gaston D; Agarwal N; Lowrance W; Schiffman J; Kohlmann W
    Fam Cancer; 2017 Oct; 16(4):545-550. PubMed ID: 28315974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.
    Minelli A; Maserati E; Rossi G; Bernardo ME; De Stefano P; Cecchini MP; Valli R; Albano V; Pierani P; Leszl A; Sainati L; Lo Curto F; Danesino C; Locatelli F; Pasquali F
    Genes Chromosomes Cancer; 2004 Jul; 40(3):165-71. PubMed ID: 15138996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Referral patterns and genetic testing outcomes in a contemporary hereditary renal cancer clinic.
    McFadden J; Hardesty J; Schroeder C; Vance GH; Boris RS
    Urol Oncol; 2024 Mar; 42(3):72.e19-72.e25. PubMed ID: 38267302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.